NDPP-Flex for Prediabetes
(NDPP-Flex Trial)
Trial Summary
What is the purpose of this trial?
This trial compares a personalized diabetes prevention program (NDPP-Flex) to the standard program in 200 adults with prediabetes. NDPP-Flex sets individual health goals to better manage blood sugar levels. The study aims to see if NDPP-Flex is more effective, especially for diverse and underserved groups. The National Diabetes Prevention Program (NDPP) aims to reduce diabetes incidence through modest weight loss.
Do I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on anti-hyperglycemic medication like metformin.
Will I have to stop taking my current medications?
If you are taking anti-hyperglycemic medication (like metformin), you cannot participate in this trial. The protocol does not specify about other medications, so it's best to discuss with the trial team.
What data supports the idea that NDPP-Flex for Prediabetes is an effective treatment?
The available research shows that NDPP-Flex, a version of the National Diabetes Prevention Program, is effective in helping people with prediabetes. For example, a study found that when the program was delivered through a rural community service using Zoom, 44% of participants achieved a weight loss of 5% or more, which is a key goal for reducing diabetes risk. This was significantly better than another group using Facebook, where only 7% achieved the same weight loss. Additionally, the program helped many participants reach the goal of 150 minutes of physical activity per week, which is important for preventing diabetes.12345
What data supports the effectiveness of the NDPP-Flex treatment for prediabetes?
The NDPP-Flex treatment, an adaptation of the National Diabetes Prevention Program, shows promise in helping individuals set and achieve personalized goals to reduce diabetes risk. A study found that a similar program delivered in rural areas led to significant weight loss and increased physical activity, which are key factors in preventing diabetes.12345
What safety data is available for NDPP-Flex for prediabetes?
The provided research does not explicitly mention safety data for NDPP-Flex or its other names. The studies focus on the feasibility, effectiveness, and delivery methods of the National Diabetes Prevention Program (NDPP) and its adaptations, such as NDPP-Flex. However, they do not provide specific safety data or report any adverse effects related to the program.12346
Is the NDPP-Flex program safe for humans?
The available research on the National Diabetes Prevention Program (NDPP) and its adaptations, including NDPP-Flex, does not report any safety concerns for participants. The studies focus on behavior change and lifestyle interventions, which are generally considered safe for human participants.12346
Is NDPP-Flex a promising treatment for prediabetes?
Yes, NDPP-Flex is a promising treatment for prediabetes. It offers a flexible and personalized approach to help people set and achieve their own health goals, which can reduce the risk of developing type 2 diabetes. The program has shown potential in helping people lose weight and increase physical activity, which are important steps in preventing diabetes.12346
How is the NDPP-Flex treatment different from other treatments for prediabetes?
Research Team
Rocio Pereira, MD
Principal Investigator
Denver Health
Eligibility Criteria
This trial is for adults over 18 with prediabetes, indicated by an A1C level of 5.7-6.4%, who are patients at Denver Health and have a BMI ≥20 kg/m2 (or ≥18.5 kg/m2 if Asian). It's not open to those who've done NDPP before, take diabetes medication like metformin, are pregnant, or have been diagnosed with diabetes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants enroll in classes randomized to deliver NDPP-Flex or the standard NDPP, focusing on personalized goal setting and lifestyle intervention
Follow-up
Participants are monitored for changes in A1C and achievement of normoglycemia
Treatment Details
Interventions
- NDPP
- NDPP-Flex
NDPP is already approved in United States for the following indications:
- Type 2 diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Denver Health and Hospital Authority
Lead Sponsor
University of Colorado, Denver
Collaborator